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Abstract
In this study we demonstrate that accumulation of reactive oxygen species (ROS) is essential for E2F1 mediated apoptosis in
ER-E2F1 PC12 pheochromocytoma, and SH-SY5Y and SK-N-JD neuroblastoma stable cell lines. In these cells, the ER-E2F1
fusion protein is expressed in the cytosol; the addition of 4-hydroxytamoxifen (OHT) induces its translocation to the nucleus
and activation of E2F1target genes. Previously we demonstrated that, in ER-E2F1 PC12 cells, OHT treatment induced
apoptosis through activation of caspase-3. Here we show that caspase-8 activity did not change upon treatment with OHT.
Moreover, over-expression of Bcl-xL arrested OHT-induced apoptosis; by contrast, over-expression of c-FLIP, did not have
any effect on OHT-induced apoptosis. OHT addition induces BimL expression, its translocation to mitochondria and
activation of Bax, which is paralleled by diminished mitochondrial enrichment of Bcl-xL. Treatment with a Bax-inhibitory
peptide reduced OHT-induced apoptosis. These results point out the essential role of mitochondria on the apoptotic
process driven by E2F1. ROS accumulation followed E2F1 induction and treatment with the antioxidant N-acetylcysteine,
inhibited E2F1-induced Bax translocation to mitochondria and subsequent apoptosis. The role of ROS in mediating OHT-
induced apoptosis was also studied in two neuroblastoma cell lines, SH-SY5Y and SK-N-JD. In SH-SY5Y cells, activation of
E2F1 by the addition of OHT induced ROS production and apoptosis, whereas over-expression of E2F1 in SK-N-JD cells failed
to induce either response. Transcriptional profiling revealed that many of the genes responsible for scavenging ROS were
down-regulated following E2F1-induction in SH-SY5Y, but not in SK-N-JD cells. Finally, inhibition of GSK3b blocked ROS
production, Bax activation and the down regulation of ROS scavenging genes. These findings provide an explanation for the
apparent contradictory role of E2F1 as an apoptotic agent versus a cell cycle activator.
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Introduction
Increased expression of the E2F1 transcription factor is found in
high risk neuronal tumors and has been proposed as a factor
responsible for the initiation step of tumorigenesis [1]. E2F1 plays
an essential role in G1/S transition and directly induces the
transcription and expression of N-myc in neuroblastoma cell lines
[2]. Deregulation of N-myc is thought to play an important role in
tumor progression, with N-myc amplification strongly associated
with a poor prognosis [3]. Although it is widely accepted that E2F1
acts as a potent activator of cell cycle progression, it is known to
induce apoptosis under specific conditions [4]. The final decision
of whether E2F1 functions to mediate cell cycle progression or
apoptosis is a consequence of the integration of cellular and
environmental signals. A greater knowledge of the molecular
mechanisms by which E2F1 drives apoptosis would enhance our
understanding of its role in neuronal tumorigenesis and its
potential as a therapeutic target.
In mammals, the E2F family of transcription factors is
composed of eight members. E2F1-3 form heterodimers with
DP proteins and act primarily as transcriptional activators,
whereas E2F-4-8 primarily function as transcriptional repressors.
Activation of E2F results in the transcriptional modulation of
specific genes involved in DNA replication, development, differ-
entiation and apoptosis [5]. It has been suggested that neuronal
apoptosis can also result from de-repression, not trans-activation of
E2F-responsive genes [6]. Among the eight members of the E2F
family described above, E2F1 is unique in its ability to induce
apoptosis [4]. Over-expression of E2F1 promotes apoptosis in
several neuronal populations and is required for neuronal death
induced by a variety of stimuli [7]. Neurons lacking E2F1 (derived
from E2F12/2 mice) are largely protected from apoptosis induced
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by growth factor withdrawal, staurosporine, b-amyloid dopamine,
suggesting that E2F1 protein is essential in this response [7–9].
Despite numerous studies indicating the participation of E2F1
in neuronal apoptosis, the mechanism through which E2F1
induces apoptosis is not well understood. E2F1 has been
demonstrated to participate in both, extrinsic and intrinsic
apoptotic pathways. In lung adenocarcinoma cells, E2F1
induces the extrinsic apoptosis by down-regulating the expres-
sion of FLICE-inhibitory protein short, leading to caspase-8
activation by the death-inducing signaling complex [10].
However, others have demonstrated that E2F1 promotes the
transcription of Bid and caspase-8, molecules that link death
receptor signaling to the activation of apoptotic mechanism in
mitochondria [11]. Consistent with the intrinsic pathway, in
cultured cerebellar granule neurons, cells lacking E2F1 were less
susceptible to Fas-mediated apoptosis in comparison to their
wild type counterpart [12].
The activation of intrinsic apoptotic pathway by E2F1 occurs
via both p53-dependent and p53-independent mechanisms. In
the first step of the p53-dependent pathway, E2F1 activates the
transcription of the tumor suppressor ARF. ARF drives the
accumulation of p53 protein via the direct association and
inhibition of the p53-ligase, Mdm2. E2F1 can also signal
apoptosis independently of p53 by directly activating the
transcription of p53 family member, p73. In addition, Bcl-2
family members have been found to be direct targets of E2F1
such as Bak, Bax, PUMA, Noxa, Bim, HrK, and Apaf-1,
whereas E2F1 represses the transcription of anti-apoptotic
protein Mcl1 [13]. Finally, alternative models suggest that
E2F1 can potentiate apoptosis through generation of reactive
oxygen species (ROS), either by inhibiting NF-kB or by
transcriptional upregulation of NADPH oxidase NOX4 [14,15].
We have shown previously that over-expression of E2F1
induces apoptosis in naive as well as differentiated pheochro-
mocytoma cell line PC12 [16]. Here we show that the E2F1-
induced ROS production is required for the apoptotic functions
of E2F1. These findings provide an explanation for the
apparent contradictory role of E2F1 as an apoptotic agent
versus a cycle activator.
Materials and Methods
Cell Culture, Transfection and Plasmids
ER-E2F1 PC12 rat pheochromocytoma stable cells were
cultured in DMEM high glucose media without pyruvate and
supplemented with 12% of heat-inactivated serum (6% fetal
bovine serum and 6% horse serum)(all from Gibco, UK) in the
presence of 0,5 mg/ml of the selective agent geneticin (Sigma-
Aldrich, USA). The neuroblastoma ER-E2F1 stable cell lines SH-
SY5Y and SK-N-JD were grown in DMEM containing 10% fetal
bovine serum and RPMI 10% fetal bovine serum plus 1% L-
Glutamine, respectively [16]. For proper cell attachment, all
experiments were performed in plates coated with 0,1 mg/ml
poly-DL-ornithine for PC12 cells and with fibronectin at 4,5 mg/
ml for neuroblastoma cells (both from Sigma-Aldrich, USA). ER-
E2F1 translocation to the nuclei was achieved by incubating cells
with 400 nM of 4-hydroxytamoxifen (OHT) (Calbiochem USA).
The set of inhibitors used in this study was N-Acetyl-Cysteine
(NAC) at 1 mM, Diphenyleneiodonium Chloride (DPI) at 500 nM
(both from Sigma-Aldrich, USA), Bax-inhibiting peptide V5
(Calbiochem USA) and LiCl at 40 mM (Merck, USA). For the
latter a pre-incubation period of 30 minutes was performed, and
for all treatment conditions the control cells were treated with
dimethylsulfoxide (DMSO). DMSO concentrations did not exceed
0,05%.
Caspase-3 and -8 Assay
Caspase activities were measured by colorimetric assays assess-
ing the cleavage of Ac-DVED-pNA substrate for caspase-3; and of
Ac-IETD-pNA for caspase-8 (both from BD Biosciences, USA).
Cells treated for the indicated times were washed once with ice-
cold PBS and lysed on ice with 100–150 ml of ice-cold caspase lysis
buffer (0,1% Triton X100, 150 mM NaCl, 50 mM HEPES
pH7.4, 0,1 mM EDTA, 1 mM dithiothreitol, 1 mM DTT). The
lysate was incubated in constant agitation for 30 min at 4uC, and
finally centrifuged at maximum speed for 5 min at 4uC. After
determination of protein content samples containing 30 mg of total
cell lysate (caspase-3) or 100 mg (caspase-8) were assembled in
duplicate in 96-well plates with freshly-prepared reaction buffer 2x
(caspase lysis buffer supplemented with 20% glycerol and 20 mM
DTT), and 100 mM of the adequate pNA colorimetric substrate
was added to each well. The reaction mixture was incubated
protected from light for 2 h at 37uC. Cleavage of the substrate by
caspases releases pNA, detected by absorbance at 405 nm with
a microplate reader. Caspase activity results are expressed as units
of pNA absorbance per mg of protein.
TUNEL Assay
PC12 cells were grown and treated in poly-DL-ornithine coated
6 well plates (16105 cells per well) or 24 well plates (26104 cells
per well). Cells were primary fixed by addition of 8% para-
formaldehyde to the growth media for 30 min at room temper-
ature. All media was then removed and cells were fixed with 4%
paraformaldehyde for another 30 min at room temperature. After
washing with PBS and PBS-T (PBS +0,3% TritonX-100), cells
were blocked for 30 min with a 2% BSA, 0,3% TritonX-100
solution in PBS. They were washed again with PBS-T and
incubated in reaction mixture for 2 hours at 37uC. Wells were
isolated with parafilm to prevent them from drying and plates
protected with aluminium foil paper to protect them from light.
The composition of reaction mixture for 50 ml was as follows:
0.5 ml Terminal Transferase, 10 ml TdT Reaction Buffer (56),
5 ml CoCl2 25 mM (all from Roche, Germany), 0.5 ml Chroma-
Tide Bodipy FL-14-dUTP (Molecular Probes, USA) and 1.5 ml
Triton X-100 10% in H2O. For nuclear staining, cells were then
incubated with 2 mg/ml Hoechst 33258 (Molecular Probes, USA)
in PBT for 30 min at room temperature. Wells were washed in
PBT and PBS and mounted in slow-fade light anti-fade solution.
Cells were visualized under fluorescence microscopy. Each
random field of cells was visualized for total nuclei counting
(345/478 nm for Hoechst 33258 fluorescence), and for apoptotic
nuclei counting (505/515 nm for Bodipy-FL fluorescence). Results
were expressed as an apoptotic index defined as the number of
apoptotic cells divided by number of total cells.
Western Blot
Cells were harvested with growth media, and washed once with
ice-cold PBS. After centrifugation, the cell pellet was resuspended
and incubated for 30 min at 4uC in lysis buffer (20 mM Tris-HCl
pH 8.0, 10 mM EDTA, 2,5 mM MgCl2, 1% Triton X100 with
a supplement of 1 mM DTT and 1/100 dilution of phosphatase
and protease inhibitor cocktail (Sigma Aldrich, USA). Equal
amounts of protein lysate were subjected to 12% sodium
dodecylsulphate (SDS) polyacrylamide gel electrophoresis and
electrophoretically transferred to PVDF membranes. The mem-
branes were then blocked with 5% non-fat milk solution in TBS-T
(TBS with 0,1% Tween20) for 1 hour at room temperature and
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Figure 1. The extrinsic apoptotic pathway is not involved in E2F1-induced apoptosis. (A, B) Stable ER-E2F1 PC12 cells were treated (+) or
not treated (2) with OHT in the presence or absence of serum for the indicated hours. Cells were collected and lysed, and caspase-8 (A) or caspase-3
(B) activities were analysed using the pNA colorimetric assay as indicated in Material and Methods. (C) Stable ER-E2F1 PC12 cells were treated with
OHT at the indicated times. Mitochondrial fractions were obtained and expression of the indicated proteins was determined by Western blot. Results
are presented as Mean 6 SEM, for n = 3. Student’s t-test value of **p,0,01 was considered statistically significant.
doi:10.1371/journal.pone.0051544.g001
E2F1 and ROS
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immunoblotted. The primary antibodies used were the following:
CycE, Bax, N-Myc, p53, GSK3b, WLAG tag (Santa Cruz
Biotechnology, USA); Bim, Noxa, Puma, Mcl-1 (Cell Signaling,
USA); tBid (R&D Systems, USA); Bcl-xL (BD Transduction
Laboratory, USA); Tubulin (Calbiochem, Germany); MnSOD
(Upstate, USA) and HA Hemagglutinin Tag (Sigma, USA). Both
incubations with primary and secondary horseradish peroxidase-
conjugated antibodies (Santa Cruz Biotechnology, USA) were
performed in 5% non-fat milk TBS-T solution for 2 h and 1 h,
respectively. Blots were developed using an Enhanced Chemilu-
minescence kit (Amersham, UK).
PCR
Following treatment, total RNA was extracted using Ultraspec
Total RNA Isolation from Tissues/Cells (Biotecx USA). 1 mg of
total RNA was subjected to reverse transcription and the resulting
cDNA samples were used in PCR amplification using KapaTaq
Polymerase (KapaBiosystems, USA). The sequences of the PCR
primers used were as followed: Bim, 59-
GGCCTGGGGCCCCTACCTCCCT-39 (forward), and 59-
CCGCCGCAGCTCCTGTGCGAT-39 (reverse); Cyc E, 59-
TCAGACCGCCCAGAGCC TCC-39 (forward), and 59-
CCCCGGAGCAAGCACCATCA-39 (reverse); and Actin, 59-
Figure 2. Effect of over-expression of Bcl-xL and cFLIP in E2F1-induced apoptosis. Stable ER-E2F1 PC12 cells were transfected or not with
Bcl-xL (A) or cFLIP (B) expression plasmids and treated (+) or not treated (2) with OHT. At 48 hours, apoptotic cells were identified by TUNEL and
counted against 100 nuclei identified by Hoescht staining in randomly taken photographs. Results are presented as Mean 6 SEM, for n= 3.
Statistically significant differences were obtained comparing with cells untransfected. Student’s t-test value of **p,0,01 was considered statistically
significant. Expression of the transfected proteins were measured by Western Blot analysis and shown on the right of the figures. HA antibody was
used for Bcl-xL detection and FLAG for FLIP. Arrow indicates FLIP position and asterisk a non specific protein.
doi:10.1371/journal.pone.0051544.g002
E2F1 and ROS
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CAGAGCAAGCGAGGCATCCTG-39 (forward), and 59-
GTTGAAGGTCTCAAACAT GATC-39 (reverse).
RT2 Profiler PCR Array
RNA from SH-SY5Y and SK-N-JD ER-E2F1 stable cell lines,
treated in the different conditions, was extracted using the
RNeasyH Mini Kit (SABiosciences, Frederick, MD) and converted
to cDNA by using the RT2 First Strand Kit (SABiosciences,
Frederick, MD). Quality of cDNA was confirmed with the RT2
Profiler PCR Array own controls, which tests for RNA integrity,
inhibitors of reverse transcription and PCR amplification and
genomic and general DNA contamination. Gene expression was
analyzed in every cell condition by using the Human Oxidative
Stress and Antioxidant Defense RT2 Profiler PCR Array
(SABiosciences), which profiles the expression of 84 genes related
to oxidative stress. PCR amplification was performed on an ABI
Prism 7900HT sequence.
Transfection and Luciferase Assay
Cells were transfected with 4 mg of YFP-Bax plasmid (kindly
provided by Dr. Andrew Gilmore), or ER-E2F1 plasmid (kindly
provided by Dr. Kristian Helin) or pcDNA.3-3HA-hBclxL and
pEIGW-SK-mFLIP-FLAG plasmids (kindly provided by Dr. Joan
Comella), or NF-kB and E2F luciferase reporter vectors using
10 ml of Lipofectamine 2000 (Invitrogen, USA) in accordance with
the manufacturer’s instruction. To obtain the ER-E2F stable cell
lines, cells were re-suspended and incubated in D-MEM selective
medium, containing 10% serum and 750 mg/ml Geneticin
Selective Antibiotic (G418) (Gibco, UK). After 15 days, the
transfected stable cell line was obtained and maintained in the D-
MEM selective medium. Luciferase activity was measured using
either the Luciferase Assay kit (Promega, USA) in accordance with
the manufacturer’s recommendations and normalized with protein
content in the case of the NF-kB-promoter assay, or the renilla
luciferase in the case of the E2F1-promoter assays.
Localization of YFP-Bax
Cells transfected with YFP-Bax plasmid vector were carefully
resuspended in culture medium and redistributed into 6-well plates
covered with glass coverslips and coated with poly-DL-ornithine.
Following cell adhesion, the cells were treated in the different
conditions for 3 h, and during the last 15 minutes of incubation,
the cells were stained for mitochondria with 50 nM of Mito-
Tracker CMX-ROS (Invitrogen, USA). Finally, cells were fixed
with 4% paraformaldehyde in PBS for 15 min at room
temperature, washed with PBS, mounted with Fluoroshield
(Sigma-Aldrich, USA) and visualized in a Leica DMI 4000 B
microscope with the appropriate filters.
Immunofluorescence of Activated Bax
Cells were grown on poly-DL-ornithine-coated 6-well plates
with glass coverslips and treated with OHT for 3 h. During the last
15 minutes of incubation, cells were stained for mitochondria with
MitoTracker CMX-ROS at 50 nM (Invitrogen, USA). At the end
of treatment cells were fixed with 4% paraformaldehyde during
15 min with constant agitation, washed with PBS, permeabilized
Figure 3. Expression analysis of reported E2F1-target genes in ER-E2F1 PC12 cells. (A) Serum-deprived cells were treated (+) or not treated
(2) with OHT for the indicated hours. Expression of the indicated proteins was determined by Western Blot analysis. (B) Total mRNA was extracted
and the levels of indicated transcripts were analyzed by RT-PCR. (C) ER-E2F1 PC12 cells were serum deprived and treated with OHT for the indicated
hours, or with 400 mM of H2O2 for 6 hours. Mitochondrial fractions and cytoplasmic (cyto) fractions were obtained and analyzed for the indicated
protein contents by Western blot analysis.
doi:10.1371/journal.pone.0051544.g003
E2F1 and ROS
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for 2 min with 0,2% CHAPS and then incubated for 1 h with
1:200 anti-Bax antibody 6A7 clone (BD Bioscience, USA) in 10%
horse serum to detect mitochondrial activated Bax. After several
washes in PBS, cells were incubated with the secondary antibody
Alexa 488-conjugated anti-mouse IgG at 1:100 dilution (Molec-
ular Probes, USA) in 10% horse serum for 1 h, washed again, and
then mounted with Fluoroshield (Sigma-Aldrich, USA). The
fluorescence was detected in a Leica DMI 4000 B microscope
with the appropriate filters.
Mitochondria Isolation and Crosslink of Bax
Cells were washed once in PBS, suspended in 500 ml hypotonic
buffer (10 mM NaCl, 1,5 mM MgCl2, 10 mM Tris-HCl, pH 7,5)
and incubated on ice for 10 min. Cells were ruptured with 20
strokes with a tight-fitting pestle in a Dounce homogenizer, 400 ml
of 2,5x buffer B (525 mM mannitol, 175 mM sucrose, 12,5 mM
Tris-HCl, pH7,5, 2,5 mM EDTA, ph 7,5) was added, and
mitochondria were isolated by differential centrifugation. Samples
were centrifugated at 1,3006g for 10 min at 4uC, supernatants
were transferred to clean tubes, and centrifugation was repeated
twice. The resulting supernatants were then centrifugated at
17,0006g for 20 min at 4uC to pellet mitochondria. The
mitochondrial pellet was washed once with 1x buffer B and re-
centrifugated. Cross-linking reactions were then performed on the
mitochondrial pellets suspended in 200 ml PBS by treatment with
1 mM bismaleimidohexane (Pierce, USA) for 30 min at room
temperature. Mitochondria were pelleted and suspended in
sample buffer supplemented with 10 mM DTT to quench the
cross-linking reaction. Samples were then subjected to immuno-
blot analysis with anti-Bax antibody (Santa Cruz Biotechnology,
USA) to detect oligomeric Bax.
Detection of ROS
Cells were incubated with 2,5 mM H2DCFDA (Invitrogen,
USA) at 37uC in HBSS without red phenol, lysed for 10 min at
4uC with lysis buffer (25 mM HEPES pH 7,5, 60 mM NaCl,
1,5 mM MgCl2 and 0,1% Triton X-100) and then transferred in
duplicate to a 96-well plate. Fluorescence of the DCF subproduct
was measured in a Microplate Fluorescence Reader Fluorstar
Optima and expressed as percentage of control after correction
with protein content.
Results
Bax Activation is Implicated in the E2F1-induced
Apoptosis
Previously we demonstrated that in PC12 cells over-expression
of E2F1, employing the ER-E2F1 fusion protein, induces apoptosis
through activation of caspase-3 [16]. To investigate the mecha-
nism by which E2F1 controls apoptosis, we asked whether this was
through an extrinsic or intrinsic pathway, both of which have been
shown to be induced by E2F1, depending on cell type [11–13,17].
The ER-E2F1 fusion protein is expressed in the cytosol; with 4-
hydroxytamoxifen (OHT) treatment inducing its translocation to
the nucleus [16]. Induction of the extrinsic pathway was measured
by following the activation of caspase-8. As is shown in Fig. 1A
caspase-8 activity did not change upon treatment with OHT either
in the presence or absence of serum. In agreement with previous
reports that serum deprivation induces the activation of the
extrinsic apoptotic pathway, increased caspase-8 activity was
found in all of conditions where serum was absent [18]. Caspase-8
activity was also determined by measuring the endogenous
cleavage of Bid, a well-known substrate of caspase-8 [19]. As is
shown in Fig 1B, serum deprivation induced the appearance of the
proteolytic form of Bid, tBid, to mitochondria, however, treatment
with OHT did not produce any further increase. In addition, we
measured the expression of Bid on the total cell extract after serum
starvation and OHT addition. As shown in Fig S1, in these
conditions we were not able to detect the cleavage of Bid and Bid
levels remained constant. Probably, only a small amount of Bid is
cleavage and translocate to mitochondria compared to the full Bid
protein and as a consequence, the change on full Bid proteins are
difficult to detect. That OHT treatment led to E2F-transcriptional
activation is demonstrated by the induction of of Cyc E, an E2F1
cell cycle target [20]. In parallel, addition of OHT led to increased
caspase-3 activity as shown in Fig 1C and to the induction of
apoptosis as measured by the appearance of sub-diploid DNA
peak by Scatter analysis as shown in Fig. S2. These findings argue
that E2F-induced apoptosis is mediated by an intrinsic, rather than
an extrinsic pathway. In order to confirm the involvement of the
intrinsic pathways on the E2F1-induced apoptosis, we measured
the effect of over-expression of Bcl-xL on this process. As is shown
in Fig 2A, over-expression of Bcl-xL arrested OHT-induced
apoptosis. By contrast, over-expression of c-FLIP, a caspase
homologue that is thought to be an inhibitor of death-receptor-
mediated apoptosis, did not arrest OHT-induced apoptosis as
shown in Fig. 2B.
The intrinsic apoptotic pathway is dependent on the balance
between pro- and anti-apoptotic members of the Bcl-2 superfamily
members. Previous studies demonstrated that over-expression of
E2F1 regulates the expression of many pro- and anti-apoptotic
proteins [21]. Because the transcriptional regulation of these genes
and their contribution to E2F1-induced apoptosis is cell type
dependent, we assessed the pattern of Bcl-2 expression after the
E2F1-induction. Cells were serum deprived and the expression of
Bcl-2 target genes was determined at different times after OHT
addition. CycE expression was used as a positive control of E2F1-
transcriptional activity regulation. As it is shown in Fig. 3A,
induction of E2F1 led to the expression of BimL, but none of the
other members of the Bcl-2 family including Bax, Bcl-xL, Noxa,
Figure 4. E2F1 induces Bax activation, dimerization and translocation to the mitochondria. (A) PC12 ER-E2F1 cells were transiently
transfected with an YFP-Bax plasmid, serum-deprived and treated with (OHT) or without (control) OHT for 3 hours. YFP-Bax localization was achieved
by immunofluorescence as indicated in Material and Methods. Red signal represents the mitochondrial staining with MitoTracker and green signal
represents Bax-YFP localization. (B) Quantification of the punctuated mitochondrial clusters of YFP-Bax from the experiments described in A. (C) PC12
ER-E2F1 cells were serum-deprived and treated with (OHT) or without (control) OHT for 3 hours and active Bax was detected by immunofluorescence
using anti-Bax 6A7 clone antibody. Red signal represents the mitochondrial staining with MitoTracker and green signal represents active Bax. (D)
Quantification of the positive anti-BAx 6A7 from experiments described in C. (E) PC12 ER-E2F1 cells were treated with OHT at the indicated times and
harvested and the mitochondria fraction was isolated. Crosslinking reactions were performed on the mitochondrial pellets as indicated in Materials
and Methods. Samples were subjected to Western blot analysis and probed with anti-Bax antibody. (F) PC12 ER-E2F1 cells were treated with 50 mM of
Bax-inhibiting peptide in the presence or in the absence of OHT. At 72 hours, apoptotic cells were identified by TUNEL and counted against 100
nuclei identified by Hoescht staining in randomly taken photographs. Results are presented as Mean 6 SEM, for n= 3. Statistically significant
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Puma, and Mcl1. RT-PCR analysis demonstrated that the
increase in BimL protein expression correlated with an increase
in the expression of its cognate mRNA as shown in Fig. 3B. The
levels of p53, N-Myc and GSK3b proteins, whose expressions are
regulated by E2F1 in other experimental systems, did not change
under our experimental conditions [2,22,23]. These data demon-
strate that E2F1 regulates BimL expression by regulating its
mRNA levels, and suggest a role of this protein in the apoptotic
function of E2F1 in PC12 cells.
Re-localization of Bax from the cytosol to the mitochondria
represents one of the first steps in programmed cell death in
neurons [24]. To investigate whether over-expression of E2F1
promotes the translocation of Bax to mitochondrial compartment,
cytosolic and mitochondrial extracts were obtained at different
times after OHT treatment and the amount of mitochondrial-
associated Bax was determined. As shown in Fig. 3C, addition of
OHT induced the re-localization of Bax to mitochondria in a time-
dependent manner, which was paralleled by a decrease in the
amount of anti-apoptotic Bcl-2 member, Bcl-xL, localized with
Figure 5. E2F1 enhanced ROS production is essential for the apoptotic function. (A) PC12 ER-E2F1 cells were serum deprived and treated
with OHT for the indicated hours. ROS levels were analysed by using the oxidation-sensitive fluorescent probe H2DCFDA as described in Material and
Methods. Results are presented as Mean 6 SEM, for n = 6 (B) Stable ER-E2F1 PC12 cells were treated with (+) or without OHT in the presence (+) or in
the absence (2) of 1 mM NAC, or in the presence (+) or in the absence of 40 mM LiCl or serum for 4 hours. After cell collection and lysis, caspase-3
activity of cell extracts was analysed by using the pNA colorimetric assay as indicated in Material and Methods. Results are presented as Mean6 SEM,
for n = 3. (C) ER-E2F1 cells were transiently transfected with YFP-Bax, treated for 3 hours with (+) or without (2) OHT in the presence (+) or absence
(2) of 1 mM NAC, and the punctuated mitochondrial clusters of YFP-Bax were quantified by immunostaining analysis. Results are presented as Mean
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mitochondria. Hydrogen peroxide, a potent inducer of apoptosis,
was used as a positive control for Bax and Bcl-xL translocation,
and Cox IV, as a protein loading control. To confirm the role of
E2F1 on Bax intracellular distribution, we evaluated its localiza-
tion by transfecting PC12 ER-E2F1 stable cells with a YFP-Bax
fusion construct. As is shown in Fig 4A and B, most of the
untreated cells displayed a cytosolic pattern of fluorescence.
However, the addition of OHT produced significant changes in
the distribution of the fluorescence: from a diffuse, cytosolic
distribution to a punctuated pattern of fluorescence. This change
was shown to represent the redistribution of Bax to the
mitochondria, as demonstrated by the overlap between YFP-Bax
fluorescence and the localization of mitochondria revealed by
staining with MitoTracker.
Insertion of Bax into the mitochondria implies changes in Bax
conformation, together with its oligomerization; processes which
are essential for its apoptotic function [24–26]. To examine
whether E2F1 induced a change in the conformation of Bax, we
carried out an immunofluorescence labeling analysis by staining
untreated and OHT treated cells with the conformation-sensitive
Bax 6A7 antibody. This antibody recognizes the NH2-terminal
Bax epitope that is exposed to the external mitochondria
membrane as a consequence of the Bax conformational change
[26]. As shown in Fig. 4C, 6A7 immunofluorescence label was
absent in untreated cells, however it was present in OHT-treated
cells. The 6A7 immunofluorescence label localized with the
subcellular marker MitoTracker, demonstrating that active Bax
resides on mitochondrial vesicles. Furthermore, analysis of Bax
oligomers by chemical crosslinking, revealed that the addition of
OHT induced the appearance of one band that possesses
molecular weight coincident with the dimeric form of Bax
(Fig. 4E). Thus, E2F1 activation induces mitochondrial trans-
location and activation of Bax, a response which parallels E2F1-
mediated apoptosis. To determine the functional relevance of Bax
in E2F1-apoptosis, we employed a commercially available peptide
that was previously shown to bind directly to Bax, prevent its
mitochondrial translocation, and inhibit Bax mediated apoptosis
[27]. As shown in Fig. 4F, treatment with the Bax-inhibitory
peptide reduced OHT-induced apoptosis. These results point out
an essential role of Bax on the apoptotic process driven by E2F1.
Generation of Reactive Oxygen Species is Essential for
E2F1 Induced Apoptosis
Reactive oxygen species (ROS) have been implicated in the
regulation of neuronal apoptosis in several neurodegenerative
diseases. To examine the role of ROS in E2F1-dependent
apoptotic process [28], its accumulation was measured fluorome-
trically using the oxidation-sensitive fluorescent probe 29-79-
dichlorodihydrofluorescein diacetate (H2DCFDA) [26].
H2DCFDA is hydrolyzed and oxidized to fluorescent 29,79-
dichlorofluorescein (DCF) by ROS. Treatment of PC12-ER-
E2F1 cells with OHT caused an increase in ROS as evidenced by
the dramatic increase of DCF fluorescence (Fig 5A). Levels of DCF
were increased in a time-dependent manner, indicating an
Figure 6. Apoptotic function of E2F1 is correlated with its
ability to induce ROS accumulation. (A) Indicated SH-SY5Y and SK-
N-JD neuroblastoma ER-E2F1 stable cell lines were treated (+) or not
treated (2) with OHT, in the presence (+) or absence (2) of serum for 4
hours. Cell extracts were collected and lysed, and caspase-3 activities
(left panels) and ROS levels (right panels) were analysed as described in
Material and Methods. (B) Indicated SH-SY5Y and SK-N-JD neuroblas-
toma ER-E2F1 stable cell lines were treated (OHT) or not treated
(control) with OHT for 4 hours. Cells were immunostained for E2F1
protein (red) and DAPI (blue). (C) Indicated SH-SY5Y and SK-N-JD
neuroblastoma ER-E2F1 stable cell lines were transfected for 16 hours
with a E2F luciferase reported construct and treated with (+) or without
(2) OHT. Luciferase was measured and normalized for Renilla luciferase
readings in the same extracts and the values were indicated. Results are
presented as Mean6 SEM, for n = 4. In all figures, Student’s t-test values
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accumulation of ROS during the apoptotic process. To answer the
question as to whether ROS is involved in the induction of
apoptosis by E2F1, we determined the effect of N-acetylcysteine
(NAC), a well-known free radical scavenger, on this process.
Apoptosis was determined by measuring the change on caspase-3
activity as reflected by DEVD-AFC cleavage. As shown in Fig 5B,
the addition of NAC prevented OHT induced-activation of
caspase-3. As predicted from our earlier studies, the addition of
either LiCl or serum to the cell medium inhibited the E2F-induced
apoptosis [16]. To determine whether ROS is responsible for Bax
activation, we measured the effect of NAC on the translocation of
transfected Bax-YFP fusion construct into mitochondria. Results
demonstrate that such treatment decreased the re-localization of
Bax from the cytosol to the mitochondria, as measured by the
YFP-Bax fluorescence assay (Fig. 5C). We excluded any inhibitory
role of NAC on the transcription activity of E2F1 by confirming
that the transcription levels of E2F reported construct B-Myb-
luciferase did not change after NAC treatment (results not shown).
These results strongly imply that production of ROS is essential for
the apoptotic effect of E2F1 in PC12 cells and suggest that
generation of ROS could be the initiation event for the apoptotic
response.
Next we investigated whether this finding could be extended to
other neuron cell lines. To this end, we stable transfected SH-
SY5Y and SK-N-JD neuroblastoma cells with ER-E2F1 expres-
sion vector and measured apoptosis and ROS production after the
addition of OHT. As shown in Fig. 6A, the presence of OHT
increased caspases-3 activity as well as ROS production in SH-
SY5Y cells. In contrast in SK-N-JD cells, activation of E2F1 by the
addition of OHT did not affect ROS production, and in-
terestingly, there was no effect on apoptosis. This was not due to
a failure to induce E2F1, as immunofluorescence studies show that
the addition of OHT induced the translocation of ER-E2F1 to the
nuclei equally in both cell types (Fig. 6B). Likewise, co-transfection
of both cell types with ER-E2F1 and an E2F-luciferase reporter
shows that OHT induced E2F1 transcriptional activity to a similar
extent (Fig. 6C). These data demonstrate that the differential
Figure 7. E2F1 does not regulate the ROS levels through Nox, but is capable to modulate NF-kB activity. (A) PC12 ER-E2F1 cells were
serum deprived and treated with (+) or without (2) OHT in the presence (+) or absence (2) of DPI for 4 hours. After cell collection and lysis, caspase-3
activity of cell extracts was analysed by using the pNA colorimetric assay as indicated in Material and Methods. (B) Stable ER-E2F1 PC12 cells were
treated with (+) or without OHT, in the presence (+) or in the absence (2) of 1 mM NAC, or DPI for 4 hours. ROS levels were analysed by using the
oxidation-sensitive fluorescent probe H2DCFDA as described in Material and Methods. (C) Serum-deprived cells were treated (+) or not treated (2)
with OHT for the indicated hours. Expression of the referred proteins was determined by Western Blot analysis. (D) Stable ER-E2F1 cells were
transfected for 16 hours with a NF-kB reported construct and treated with (+) or without (2) OHT in the presence (+) or absence (2) of 1 mM NAC for
4 hours. Luciferase was measured and normalized with protein content. Results are presented as Mean 6 SEM, for n = 3. In all of the figures, data are
compared as indicated individually. Student’s t-test values of *p,0,05, **p,0,01 and ***p,0,0001 were considered statistically significant.
doi:10.1371/journal.pone.0051544.g007
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ability of E2F1 to induce apoptosis in SH-SY5Y versus SK-N-JD
cells correlates with its ability to generate ROS.
E2F1 Regulates the Expression of a Large Number of
Genes Involved on ROS Metabolism
The steady-state levels of ROS are controlled by the rate of
ROS production and clearance by scavenging mechanisms. The
major ROS-generating systems in cells include the mitochondria
and the seven known NOX isoenzymes [29–31]. Although ROS is
Figure 8. Heatmap of oxidative and antioxidative genes regulated by E2F1.mRNA from ER-E2F1 SH-SY5Y was isolated from OHT treated or
not treated cells and quantified using the RT2 qPCR array platform as described in Material and Methods. All OHT regulated genes were compared
against controls, using Hypoxanthine phosphoribosyltransferase 1 gene as the reference. The relative magnitude of expression is indicated on
a spectrum ranging from minimum (green) to the maximum detected (red). All genes tested in the array are listed on Table S1.
doi:10.1371/journal.pone.0051544.g008
Figure 9. LiCl inhibits ROS production and Bax activation induced by E2F1. (A) PC12 ER-E2F1 cells were serum deprived and treated with
OHT (+) or not (2) with OHT, in the presence (+) or in the absence (2) of 40 mM LiCl for 4 hours. ROS levels were analysed by using the oxidation-
sensitive fluorescent probe H2DCFDA as described in Material and Methods. Results are presented as Mean 6 SEM, for n = 4. (B) PC12 ER-E2F1 cells
were transiently transfected with an YFP-Bax plasmid, serum deprived and treated with OHT (+) or not (2) with OHT, in the presence or absence of
40 mM LiCl for 3 hours. Quantification of the punctuated mitochondrial clusters of YFP-Bax achieved in the immunofluorescence assay is described in
Material and Methods. Results are presented as Mean 6 SEM, for n= 3. In all of the figures, data are compared as indicated individually. Student’s t-
test values of *p,0,05 and **p,0,01were considered statistically significant.
doi:10.1371/journal.pone.0051544.g009
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primarily generated following release of electrons from the
electron transport chain at the mitochondria, NOXs are capable
of generating ROS in a highly regulated manner [29–31]. In order
to investigate whether the intracellular accumulation of ROS after
induction of E2F1 is due to the upregulation of NOX, we have
studied the effect of NOX-inhibitor diphenyleneiodonium (DPI)
on the E2F1-induced apoptosis by measuring caspase-3 activation
[32]. As shown in Fig 7A, DPI treatment repressed caspase-3
activity in the absence or presence of OHT, however there were
significant differences in the extent of caspase-3 repression.
Similarly, DPI treatment only led to partial diminishing of ROS
levels in the presence of OHT as shown in Fig 7B. The inability of
DPI to impair ROS generation, suggests that E2F1 regulates ROS
production by mechanisms distinct from the NOXs.
As previous reports demonstrated that E2F1 represses the
expression of antioxidative enzyme Mn superoxide dismutase
(MnSOD) through inhibition of NF-kB [14], we next evaluated
whether regulation of MnSOD was implicated in the E2F1-
induced apoptotic response. To test this possibility, the expression
of MnSOD and mRNA levels were determined at different times
following OHT treatment, with CycE mRNA expression used as
a positive control. As shown in Fig 7C, the levels of MnSOD
protein remained constant after OHT induction and no change in
MnSOD mRNA levels were detected (data non shown). However,
it is possible that other antioxidative enzymes, which are
transcriptional targets of NF-kB, were responsible for the effects
of E2F1. To test if E2F1 modulates NF-kB activity, and, as
a consequence ROS content, we transfected ER-E2F1 PC12 cells
with a NF-kB luciferase reporter construct. The results show that
the addition of OHT induced a significant reduction of NF-kB
activity as shown in Fig. 7D. These results exclude the involvement
of MnSOD on the accumulation of ROS by E2F1, and suggest
a potential role for NF-kB in this process.
Because E2F1 regulates the transcription of extensive number of
genes, to fully understand the molecular mechanism mediating the
production of ROS by E2F1, we compared the mRNA profiling of
genes involved in ROS metabolism between control cells and
those exposed to OHT. To this end, mRNA levels of 84 genes
implicated in ROS production were analyzed in SH-SY5Y cells by
the Human Oxidative Stress and Antioxidant Defense TR2 PCR
array (SABioscences). This cell line was chosen because its human
origin allows us to use a commercial PCR array. Upon OHT
treatment, these gene expression profiles were significantly altered,
suggesting that both oxidative and antioxidant genes are targets of
E2F1. A heat map is shown in Fig. 8 displaying a visual
representation of these changes on gene expression. Of these
genes, fifteen display significant down-regulated response to OHT
(more than two-fold difference in expression and only two were
found up-regulated as shown in Table 1). The transcriptional
profile reveals that antioxidant functions are down-regulated,
suggesting that this global change could be responsible for the
increase of ROS levels. The same expression analysis was carried
out in SK-N-JD neuroblastoma cells, which have a very low
apoptotic response to activation of E2F1. Upon OHT treatment,
in contrast to SH-SY5Y cells, the profile of 84 genes was not
significantly affected as shown in Table S2. This suggests that
Table 1. mRNA levels changes after OHT addition in SH-SY5Y cells.
Unigen Symbol Description Fold Change
Without LiCl With LiCl
OHT #1 OHT #2 OHT #1 OHT #2
Genes downregulated
Hs.95120 CYGB Cytoglobin 0.13 0.01 0.74 1.34
Hs.502823 PRDX5 Peroxiredoxin 5 0.21 0.02 3.03 6.08
Hs.502917 CCS Copper chaperone for superoxide
dismutase
0.05 0.19 6.10 10.87
Hs.728817 TXNRD1 Thioredoxin reductase 1 0.18 0.08 3.63 4.90
Hs.134602 TTN Titin 0.22 0.05 3.63 6.11
Hs.443430 TXNRD2 Thioredoxin reductase 2 0.19 0.21 2.38 7.36
Hs.251386 PRG3 Proteoglycan 3 0.23 0.20 5.40 3.77
Hs.234742 LPO Lactoperoxidase 0.32 0.12 3.44 8.92
Hs.631770 DGKK Diacylglycerol kinase, kappa 0.17 0.33 0.64 0.94
Hs.239 FOXM1 Forkhead box M1 0.31 0.25 0.70 1.04
Hs.146559 ANGPTL7 Angiopoietin-like 7 0.19 0.41 0.65 0.95
Hs.654439 APOE Apolipoprotein E 0.25 0.36 0.69 1.64
Hs.128856 SCARA3 Scavenger receptor class A, member 3 0.43 0.20 1.14 2.32
Hs.180909 PRDX1 Peroxiredoxin 1 0.25 0.43 0.79 1.46
Hs.467554 TPO Thyroid peroxidase 0.33 0.43 2.32 2.60
Genes upregulated
Hs.333358 GPR156 G protein-coupled receptor 156 3.94 1.31 0.83 1.22
RT2Profiler human oxidative stress and antioxidant defense PCR Arrays (Bioscience) were performed according to the manufacture’s protocols. Expression levels were
compared between with and without OHT addition. Hypoxanthine phosphoribosyltransferase 1 gene was used as control for each gene expression calculation, and the
extent of change in the expression of each gene was calculated by the DCt method. Only genes whose expression was downregulated at least 2 fold are shown in the
Table. We have also removed all genes whose expression change significantly between duplicates. When DCt was over 12 and therefore expression was thought to be
extremely low, the gene was omitted from analysis.
doi:10.1371/journal.pone.0051544.t001
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oxidative and antioxidative genes of both cells respond differently
to E2F1 and may explain their different apoptotic behavior.
GSK3b Activity is Essential for the ROS Production
Induced by E2F1
As we previously demonstrated that GSK3b is required for
apoptotic function of E2F1 [16], we were interested to assess
whether it was required to modulate ROS levels induced by E2F1.
As shown in Fig 9A, inhibition of GSK3b activity by LiCl blocked
the production of DCF induced by E2F1, suggesting that GSK3b
is also necessary for ROS production. Consistent with this finding,
the presence of LiCl prevented the translocation of Bax-YFP to the
mitochondria after E2F1 activation as shown in Fig. 9B. In Fig. S3
we show similar results using CT99021, another GSK3b inhibitor.
In order to understand the inhibitory effect of LiCl on the
induction of ROS by E2F1, we determined change in mRNA
profiling after OHT treatment in the presence of LiCl. As is shown
in Table 1, upon treatment with LiCl, the negative effect of E2F1
on the expression level of the previously mentioned antioxidative
genes was abolished. These findings argue that the effects of E2F1
on ROS are mediated by GSK3b.
Discussion
Although E2F1 is over-expressed in most neuronal tumors,
studies from many laboratories, including ours, showed that it is
also an important mediator of neuronal apoptosis [16]. In order to
understand this seemingly counterintuitive role, we investigated
the mechanism by which E2F1 promotes apoptosis in neuronal
tumor cells. In this study we show that apoptotic function of E2F1
is mediated through an intrinsic signaling pathway, in which the
translocation of Bax to mitochondria is the key event. We also
provide evidence against the participation of an extrinsic
mechanism in mediating the effects of E2F1. In this respect,
others have reported that E2F1 is able to modulate the apoptotic
response by either FAS ligand or tumor necrosis factor [10–12].
Our results show that activation of E2F1 did not alter the activity
of caspase-8, strongly suggesting that death receptors are not
involved in the E2F1 apoptotic activity in PC12 cells. Consistent
with this finding, E2F1 was not able to induce changes in the levels
of Bid, a BH3-only protein whose cleavage is triggered by caspase-
8. Moreover, over-expression of Bcl-xL arrested E2F1-induced
apoptosis; and, by contrast, over-expression of c-FLIP, did not has
any effect on OHT-induced apoptosis. These results demonstrate
the implication of intrinsic pathway on the apoptosis induced by
E2F1 and point out an essential role of mitochondria in this
process.
Members of the Bcl-2 family play an important role in
regulating mitochondrial integrity. The involvement of intrinsic
pathway in the apoptosis response induced by E2F1 is largely
based on the fact that several Bcl2 family members have been
reported to be directly or indirectly regulated by E2F1 [13]. Here
we show that E2F1 induced the translocation of the pro-apoptotic
protein Bax to the mitochondria, without affecting total Bax levels.
These results are consistent with previous data demonstrating that,
in response to distinct forms of cell death stimuli, Bax is
redistributed from cytosol to the mitochondria where it induces
a decline in the mitochondria membrane potential followed by
cytochrome c release and caspase 3 activation [33]. The capacity
of Bax to promote neuronal cell death has been reported in
multiple neuronal populations, however the mechanism by which
Bax alters mitochondria membrane potential is not well defined. It
is now accepted that, after mitochondria translocation, Bax
protein forms oligomers that permeabilize the mitochondria
membrane [24–26]. Here we show that E2F1 is also able to
induce the oligomerization of Bax, and we were able to detect the
conformation change associated with its insertion into the
mitochondria. Inhibition of Bax activity by treatment with the
Bax-inhibitory peptide reduced E2F1-induced apoptosis and point
out an essential role of Bax in this process.
Pro-apoptotic genes such as PUMA, Noxa, Bim, HrK, and Bad
have been reported to be up-regulated by E2F1 induction, in
contrast to the anti-apoptotic member Mcl-1, which is repressed.
The list of Bcl-2 targets is still growing, and the functional roles of
the individual members are dependent on cell type [21]. BimL was
found to be the only Bcl-2 member whose expression levels
changed after E2F1 induction in PC12 cells. Our results are
consistent with previous reports demonstrating that E2F activity
controls the transcription of BimL by regulating the levels of myb,
a transcription factor that controls BimL transcription [34]. BimL
is a pro-apoptotic BH3-only member of Bcl-2 family that is
required for initiation of neuronal apoptosis induced by NGF
withdrawal or by other specific stimuli including UV and ER stress
[35–37]. The mechanism by which BimL activates apoptosis is still
unclear. However, several reports have noted that BimL activates
apoptosis through Bax and it has been suggested that high levels of
BimL displace Bcl-xL in the mitochondria, promoting the
insertion of Bax into the mitochondrial membrane [38–39].
Interestingly, we found that E2F1 induction diminished the
mitochondrial enrichment of Bcl-xL. It is possible that the increase
of BimL content, induced by E2F1, facilitates the re-localization of
Bcl-xL. In agreement with this model, activation of Bax by E2F1
could, in part, induce the re-distribution of the Bcl-2 members
through increasing of BimL levels.
In this study we demonstrated that the apoptotic action of E2F1
depends on the accumulation of ROS. Numerous reports have
linked oxidative stress and ROS with neuronal apoptosis, in most
cases Bax plays a central role [31]. Activation of Bax, by apoptotic
stimuli can induce an increase in the production of O2, by
blocking the electron transport chain, the main physiological
source of intracellular ROS [39]. Although we do not exclude the
participation of Bax in ROS generation, our results suggest that
production of ROS by E2F1 occurs by a Bax-independent
mechanism. We demonstrated that diminishment of ROS levels
by NAC repressed not only E2F1-induced apoptosis, but also the
translocation of Bax to the mitochondria, implying that ROS acts
upstream from Bax activation. The molecular mechanism by
which ROS leads to Bax activation is unknown. In colon
adenocarcinoma cells, it has been reported that H2O2 induces
Bax activation through modulating the oxidative state of Bax
cysteine 62 [40]. It is also possible, as described in other apoptotic
settings, that modification of intracellular pH, produced by an
increase in ROS levels, induces Bax translocation from the cytosol
to mitochondria [41]. Moreover, ROS accumulation can induce
the activation of specific signal transduction pathways, such as
those mediated by Jun NH2- terminal kinase or p38 MAP kinases,
and as a result, phosphorylate and activate Bax or other Bcl-2
members that are involved in Bax activation [42,43].
We also attempted to identify the possible sources of increased
ROS concentration by Real Time PCR array of genes involved in
ROS metabolism and oxidative stress. We found that many of the
genes responsible for scavenging ROS were down-regulated after
E2F1 induction in SH-SY5Y cells. These genes included several
peroxiredoxins, thioredoxin reductase 1, cooper chaperone for
superoxide dismutase and peroxidases, such a lactoperoxidase and
cytoglobin. Cytoglobin, whose mRNA levels changed the most
dramatically, is responsible for intracellular oxygen storage as well
as the transfer and sensing of O2 [44]. Peroxiredoxins play an
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important defensive role in degenerative brain diseases and
neuronal cell death in adults [45,46]. Copper chaperones for
superoxide dismutase activates the ROS-scavenging function of
SOD1 by delivering of Cu2+ and has been proposed for treatment
of Alzheimer’s disease [47]. Thioredoxin reductase 1 is a major
antioxidant and redox regulator in mammalian cells and has an
essential role in mammalian development and cancer [48].
Interestingly, most of the down-regulated genes also play an
antiapoptotic role; this is the case for cytoglobin, peroxiredoxin 1,
5, the copper chaperone for superoxide dismutase, and thior-
edoxin reductase [48–52]. The diminished expression of these
genes after E2F1 activation could facilitate the loss of the
protective role against cell death. To our knowledge, none of
these genes have been reported previously to be regulated by
E2F1. However, some contain evident E2F binding sites in their
promoter region, such as cytoglobin [53]. Moreover, superoxide
dismutases, peroxidases, peroxiredoxin are targeted by NF-kB
signaling pathway. A previous report demonstrated that through
inhibition of NF-kB activity, E2F1 represses the expression of the
superoxide dismutases, MnSOD, [14]. We did not observe any
change in the expression of MnSOD, following E2F1 induction
despite the fact that E2F1 inhibited NF-kB activity under the
conditions we employed. These data strongly support a model in
which the apoptotic function of E2F1 is regulated by the NF-kB
pathway.
The individual role of each of these genes on the production of
ROS remains unknown but probably the oxidative response to
E2F1 is due to the sum of their action. Although the majority of
the genes responsible for ROS scavenging were down-regulated,
others such as dual oxidase 2 and the peroxidase G protein-couple
Receptor 156 were up-regulated. An imbalance between the
differential expressions of these genes can lead to the accumulation
of ROS and drive, as a consequence, the activation of the
apoptotic response. In this respect, the lack of ROS production
and apoptosis induction observed in SK-N-JD cells after E2F1
activation could be due to the inability of E2F1 to down-regulated
the expression of ROS scavenging genes.
Several growth factors critical to cell survival and proliferation
are known to signal through ROS-dependent mechanisms in-
volving NOX [17,54]. One isoform of NOX, NOX4, is
transcriptionally regulated by E2F in vascular smooth muscle cells
[15]. We did not detect any change on NOX4 mRNA and protein
expression following E2F1 induction in PC12 cells (data not
shown). Treatment of cells with DPI, a nonspecific inhibitor of all
the Nox isoforms, but also of multiple electron transporters, was
not able to reduce E2F1-induced ROS accumulation or apoptosis.
This result is concordance, as mentioned above, with the
suggestion that genes responsible for ROS scavenging are
regulated by E2F1.
Previously we showed that apoptotic action of E2F1 required
GSK3b [16]. Here we demonstrate that GSK3b activity is
essential for the ROS production and Bax activation. Inhibition of
GSK3b by LiCl also changed the pattern of expression of E2F1-
regulated genes. Many of the genes responsible for scavenging
ROS that were down-regulated after E2F1 induction in SH-SY5Y
cells did not change, or were found at higher levels, when GSK3b
activity was abolished. This change in the expression profile could
explain the inhibitory effect of GSK3b on the ROS production
and, as a consequence, the induction of apoptosis by E2F1. The
results obtained are in agreement with previous studies showing
that inhibitors of GSK3b activity or its depletion by siRNA
treatment increase the transcriptional level of E2F1-regulated
promoters. However, the fact that GSK3b can directly modulate
transcription of E2F1-response genes, does not exclude the
possibility that GSK3b could act downstream of E2F1, and
regulate the activity of apoptotic proteins essential for cell fate
decisions. Pro-apoptotic substrates for GSK3b have not been well
characterized. Interestingly, Bax is directly phosphorylated by
GSK3b; inhibition of GSK3b activity suppressed Bax mitochon-
drial translocation, conformational activation and cytocrome c
release [55]. Moreover, inhibition of GSK3b can also lead to
nuclear accumulation of beta-catenin and interfere with E2F1
responses, as it has been suggest in Myc/E2F1-driven hepato-
carcinogenesis model [56].
The final decision of whether E2F1 induces apoptosis is
a consequence of the integration of several cellular signals, which
are cell type dependent. Over-expression of E2F1 in the
neuroblastoma cell line SH-SY5Y induced apoptosis but not in
neuroblastoma cell line, SK-N-JD, suggesting that the high activity
of E2F1 itself does not cause apoptosis. This differential behavior
correlates with the ability of E2F1 to generate ROS in SH-SY5Y,
but not in SK-N-JD. From this result and all the other results we
can conclude that generation of ROS is essential for the apoptotic
function of E2F1. We think that this finding can lead to a better
understanding of the seemingly contradictory role of E2F1 as an
apoptotic agent as well as a cell cycle activator.
Supporting Information
Figure S1 Expression analysis of Bid after OHT treat-
ment in ER-E2F1 PC12 cells. Serum-deprived (2) or not (+)
cells were treated (+) or not (2) with OHT for 8 hours. Expression
of the indicated proteins was determined in total cell extract by
Western Blot analysis.
(TIF)
Figure S2 E2F1 induces the appearance of sub-diploid
DNA peak. Stable ER-E2F1 PC12 cells were treated or not
treated with OHT in the presence or in the absence of serum.
Analysis of cell cycle was achieved by forward light scatter and was
quantified the subdiploid DNA peak of cells at the indicated
conditions.
(TIF)
Figure S3 CT99021 inhibits ROS production and Bax
activation induced by E2F1. (A) PC12 ER-E2F1 cells were
serum-deprived and treated with (+) or without (2) OHT in the
presence (+) or in the absence (2) of 10 mM CT99021 for 4 hours.
ROS levels were analysed by using the oxidation-sensitive
fluorescent probe H2DCFDA. Results are presented as Mean 6
SEM, for n= 3. Student’s t-test value of ***p,0,0001 was
considered statistically significant. (B) PC12 ER-E2F1 cells were
serum-deprived and treated with (+) or without (2) OHT in the
presence (+) or in the absence (2) of 10 mM CT99021 for 3 hours.
Active Bax was detected by immunofluorescence using anti-Bax
6A7 clone antibody and anti-BAx 6A7 positives were quantified.
(TIF)
Table S1 List of genes that are included on the Human
Oxidative Stress and Antioxidant Defense RT2 Profiler
PCR Array (Biosciences).
(DOCX)
Table S2 mRNA changes after OHT addition in SK-N-
JD cells.- RT2Profiler human oxidative stress and antioxidant
defense PCR Arrays (Bioscience) were performed according to the
manufacture’s protocols. Expression levels were compared be-
tween with and without OHT addition. Hypoxanthine phosphor-
ibosyltransferase 1 gene was used as control for each gene
expression calculation, and the extent of change in the expression
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of each gene was calculated by the DCt method. We show the
genes that were indicated on Table1.
(DOCX)
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